bullish
China Doing What It Does Best – Copying: Making Old Products/Vaccines Better & Cheaper
266 Views20 Dec 2020 13:46
China Vaccine - using its math, science, and manufacturing strength to play Doctor to the world. They were the clinical trials themselves and now playing by international trial rules.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Patrick Eng
Partner
- Chinese Liquidity in 2021 –More Easing Ahead?20 Jan 2021
- China: COVID Accelerates China As The #1 Economy By Or Before 2025 – “Rainy Day Fund Advantage”19 Jan 2021
- The Rise Of The Renminbi – Thanks To The Next Oil Crisis28 Dec 2020
- China Doing What It Does Best – Copying: Making Old Products/Vaccines Better & Cheaper20 Dec 2020
- China Gold International – COVID Logistical Challenges - Catalysts For Gold11 Dec 2020
- China Gold International: James Bond Discovers Dr. Copper - “Super Material”08 Oct 2020
x